Status:
TERMINATED
Effects of Using the Duracore Splinting Device on Patient Outcomes Related to Chest Trauma
Lead Sponsor:
CommonSpirit Health
Conditions:
Rib Fractures
Rib Fracture Multiple
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to use the Duracore splinting device to measure lung capacities of patients with rib fractures in control and experimental groups to determine if lung capacities improve w...
Detailed Description
The purpose of this study is to use the Duracore patient operated torso splinting device for patients with chest trauma, including rib fractures, to improve deep breathing and help with reduced hospit...
Eligibility Criteria
Inclusion
- Inclusion:
- Adult patient admitted to the trauma service at Penrose Hospital
- Willing and able to comply with all requirements of the study
- Active diagnosis of rib fractures
- Male or female 18 years and older
- Able to provide written informed consent to participate in the study
- Must be physically able to don and use the splinting device independently without assistance.
- Exclusion:
- \<18 years old
- History of pulmonary disease, lobectomy, or lung transplant
- Current smoker of tobacco products
- Diagnosis of flail chest
- Pregnant Women
- Prisoners
- Cognitively Impaired; must be alert and oriented x 3
Exclusion
Key Trial Info
Start Date :
December 4 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 30 2021
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT04909463
Start Date
December 4 2020
End Date
July 30 2021
Last Update
May 14 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Penrose Hospital
Colorado Springs, Colorado, United States, 80906